Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Interim Management Statement

26 Jan 2009 16:20

RNS Number : 2639M
Standard Life Euro Pri Eqty Tst PLC
26 January 2009
Β 

ο»Ώ

Standard Life European Private Equity Trust PLC

Interim management statement for the quarter ended 31 December 2008

Standard Life European Private Equity Trust PLC ("the Company") presents its interim management statement for the period from 1 October 2008 to 31 December 2008. This announcement constitutes the Company's first interim management statement for the year ending 30 September 2009Β in accordance with rule 4.3 of the UK Listing Authority's Disclosure and Transparency Rules.Β This interim statement summarisesΒ information as at 31 December 2008Β and any material developments up to 26 January 2009.Β 

Investment objective

To achieve long-term capital gains throughΒ holdingΒ a diversified portfolio of private equity funds investing predominantly inΒ Europe.

Benchmark

The Company has no defined benchmark.

Performance

The Company's audited net asset value per ordinary shareΒ ("NAV")Β wasΒ 234.8p as atΒ 30 September 2008 (diluted - 231.4p).Β The Company's NAV as at 31 December 2008Β will be announced onΒ or around 24 March 2009. The share price of the Company's ordinary shares was 66.0p as at 31 December 2008, compared to 161.0p as at 30 September 2008, a decline of 59.0% over the quarter.Β Such aΒ percentageΒ fall was similar to that experienced byΒ mostΒ of theΒ LondonΒ listed private equityΒ investment trusts over thatΒ quarter.Β Over the sameΒ quarterΒ the MSCI Europe Index (sterling adjusted)Β fellΒ 4.8% and the FTSE All Share Index fellΒ 11.0%.

Financial positionΒ 

Against a background of significant volatilityΒ and declinesΒ in financial marketsΒ generallyΒ and a lower level of activity in the European private equity market,Β the Company received distributions from its private equity fundΒ interests of Β£14.2Β millionΒ during the quarter ended 31 December 2008Β (quarter endedΒ 31 December 2007Β - Β£21.2Β million) and fundedΒ Β£20.4Β million of draw downs (quarterΒ endedΒ 31 December 2007Β - Β£43.0Β million).Β 

The Company had aggregate outstanding commitments to its private equity fund interests of Β£425.9 million as at 31 December 2008 (30 September 2008 - Β£389.2 million). The Company's outstanding fund commitments as at 31 December 2008 were positively impacted over the quarter by some of the material transactions referred to below and were negatively impacted by foreign exchange movements. Over the quarter to 31 December 2008 sterling depreciated by 18.5% and 19.3% against the euro and the US dollar respectively; these foreign exchange movements are unrealised.

As atΒ 31 December 2008Β the CompanyΒ had net indebtedness of Β£47.6Β millionΒ (30 September 2008Β -Β net indebtedness ofΒ Β£36.4Β million). AsΒ intimated in the Chairman's Statement andΒ theΒ preliminary announcement for the financial year ended 30 September 2008 the Company entered into a new Β£100 million three year syndicated revolving credit facility, led by The Royal Bank of Scotland plc, in November 2008.Β 

Material events and transactionsΒ 

The Company announced onΒ 14Β January 2009 that it had agreed the disposal of two of its private equity fund interests,Β as part of the Company's strategy of managing the quality of its portfolio and the quantum of its outstanding commitments. The Company sold itsΒ fundΒ interests in BC European VIII and Towerbrook Investors III to significant institutional investors in the private equity asset class for an aggregate Β£7.5Β million, as compared to the 30 September 2008 valuations of these fund interests, adjusted for subsequent cashflows, of Β£11.0Β million.Β TheseΒ twoΒ fund interests had aggregate outstanding commitments at the date of disposal of Β£46.7Β million, from which the Company has now been released.

The CompanyΒ alsoΒ decided to elect to cap its exposure to Permira IV as part of the recently announced restructuring of that fund. The Company made a Β£30.3Β million commitment to Permira IV in 2006Β and as at the date of the election the outstanding commitment was Β£19.4Β million. As part of the restructuring the Company has been released from Β£16.0Β million of this outstanding commitment.

Taking account of the above disposals and election, drawdowns to date and theΒ 15.8% andΒ 23.3% depreciation of sterling compared to the euro and the US dollar respectively from 1 October 2008, the Company's total outstanding commitments were Β£374.0Β million as at 23 January 2009. As at 23 January 2009 the Company's net indebtedness was Β£48.9Β million; this is before the receipt ofΒ Β£0.9Β million ofΒ proceeds from the disposal of theΒ fundΒ interest in Towerbrook Investors III.Β 

The Company is in discussions regarding the selective disposal of a limited number of its other private equity fund interests.Β In so doing, the Board and the Manager are sensitive toΒ the need to ensureΒ that the Company has sufficient outstanding commitments to benefit from future investment opportunities.

During the period from 1 October 2008 toΒ 26 January 2009 the CompanyΒ made no new private equity fund commitments.Β Β 

On 26 January 2009Β shareholders approvedΒ a final dividend forΒ the year ended 30 September 2008 of 0.7p per ordinary shareΒ at the Company's annual general meeting. ThisΒ final dividend will be paid on 30 January 2009.

For further information please contact:-

Peter McKellar of SL Capital PartnersΒ LLPΒ (0131 245 0055)

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as anΒ investment trust under Section 842 of the Income and Corporation Taxes Act 1988. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc."

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSBLGDBIBDGGCL
Date   Source Headline
4th Apr 202212:06 pmRNSChange of Name
22nd Mar 20222:14 pmRNSResult of AGM
21st Mar 202211:26 amRNSDirector Declaration
14th Mar 20225:30 pmRNSFTSE Russell Indices
14th Mar 20227:00 amRNSEstimated NAV at 28 February 2022
9th Mar 20222:07 pmRNSFirst Interim Dividend
24th Feb 20227:00 amRNSEdison review on Standard Life Private Equity Trst
14th Feb 20227:00 amRNSEstimated NAV at 31 January 2022
4th Feb 20223:24 pmRNSAnnual Report
1st Feb 202212:45 pmRNSDirector/PDMR Shareholding
27th Jan 20227:05 amRNSEstimated NAV at 31 December 2021
27th Jan 20227:00 amRNSAnnual Financial Report
6th Jan 20229:04 amRNSQuarterly disclosure
15th Dec 20217:00 amRNSEstimated NAV as at 30 November 2021
14th Dec 20213:48 pmRNSFourth Interim Dividend
6th Dec 20217:00 amRNSEdison review on Standard Life Private Equity Trst
12th Nov 20217:00 amRNSEstimated NAV at 31 October 2021
2nd Nov 20214:25 pmRNSDirector/PDMR Shareholding
14th Oct 20217:00 amRNSEstimated NAV at 30 September 2021
4th Oct 20214:15 pmRNSQuarterly disclosure
29th Sep 20217:02 amRNSEstimated NAV at 31 August 2021
29th Sep 20217:00 amRNSQuarterly Investment Update at 30 June 2021
17th Sep 20211:10 pmRNSUpdate research from QuotedData
7th Sep 20217:00 amRNSThird Interim Dividend
1st Sep 20217:00 amRNSDirectorate Change
16th Aug 202110:19 amRNSDirector/PDMR Shareholding
13th Aug 20217:00 amRNSEstimated NAV at 31 July 2021
10th Aug 20214:41 pmRNSSecond Price Monitoring Extn
10th Aug 20214:35 pmRNSPrice Monitoring Extension
5th Aug 20213:32 pmRNSDirector/PDMR Shareholding
19th Jul 202111:58 amRNSEdison issues review on Standard Life Private
14th Jul 20219:05 amRNSDirector Declaration
14th Jul 20217:00 amRNSEstimated NAV at 30 June 2021
9th Jul 20213:29 pmRNSDoc re. Half yearly report
2nd Jul 20214:35 pmRNSQuarterly disclosure
29th Jun 20217:05 amRNSEstimated NAV at 31 May 2021
29th Jun 20217:00 amRNSHalf-year Report
14th Jun 20212:48 pmRNSSecond Interim Dividend
17th May 20217:00 amRNSEstimated NAV at 30 April 2021
12th May 20214:06 pmRNSDirector/PDMR Shareholding
27th Apr 202112:21 pmRNSDirector/PDMR Shareholding
22nd Apr 20217:05 amRNSEstimated NAV at 31 March 2021
22nd Apr 20217:00 amRNSQuarterly Investment Update at 31 December 2020
9th Apr 202111:58 amRNSHolding(s) in Company
6th Apr 20214:11 pmRNSQuarterly disclosure
23rd Mar 20211:50 pmRNSResult of AGM
12th Mar 20217:00 amRNSEstimated NAV as at 28 February 2021
8th Mar 20217:00 amRNSFirst Interim Dividend
25th Feb 20217:00 amRNSEdison review on Standard Life Private Eqty Trust
12th Feb 202110:22 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.